Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-06-04

Clinical Trial Update: Defining the Decline in Endogenous Insulin Secretion in Type 1 Diabetes Diagnosed After 30 Years of Age.

View source ↗

Summary

A clinical trial update examining how endogenous insulin secretion declines in individuals diagnosed with Type 1 diabetes mellitus after age 30.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Royal Devon and Exeter NHS Foundation Trust | Conditions: Diabetes Mellitus, Type 1, Progression | Status: COMPLETED